arrow
C

Célèste Lebbé

Saint Louis Hospital
H指数:94
被引数:8.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

黑色素瘤新辅助治疗的五年生存率:国际黑色素瘤新辅助治疗协作组(INMC)更新的汇总分析

2026-10-010
OAAI
Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study

兰瑞肽,一种生长抑素类似物,在晚期 Merkel 细胞癌中的应用:一项前瞻性单臂 II 期研究

2026-09-290
OAAI
Real-World Use of Adjuvant Nivolumab for Resected Stage III–IV Melanoma: 2-Year Analysis of AdjuMel

辅助尼洛替尼用于切除后的III-IV期黑色素瘤的实-world应用:AdjuMel 2年分析

2026-08-290
OAAI
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years

原发性黑色素瘤假阴性诊断患者的生命损失年数。一项涉及9063例患者、为期28年的德国中央恶性黑色素瘤登记研究的回顾性研究

2026-07-020
OAAI
A roadmap for supporting the development of advanced therapy medicinal products in a European framework

支持先进治疗药物产品在欧洲框架下发展的路线图

2026-05-040
OAAI
Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study
2026-01-010
OA
Messages for ultraviolet-radiation protection to fair-skinned populations

关于紫外线防护的信息,面向肤色较浅的人群

2025-11-060
OAAI
Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study

度普利尤单抗治疗免疫检查点抑制剂诱导的瘙痒性皮肤病变:一项回顾性、多中心研究

2025-10-160
PRE
Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study

妊娠期晚期黑色素瘤:一项回顾性、多中心、基于注册研究的建议

2025-10-070
OAAI
Impact of reflectance confocal microscopy on surgical outcomes in lentigo maligna and lentigo maligna melanoma: A retrospective cohort study of 282 patients

反射共聚焦显微镜对皮内痣和皮内痣黑色素瘤手术结局的影响:一项包含282名患者的研究回顾性队列研究

2025-10-010
PRE
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial

新辅助PD-1和LAG-3靶向双特异性抗体与其他免疫检查点抑制剂联合治疗可切除黑色素瘤:随机Ib/II期Morpheus-Melanoma试验

2025-09-240
OAAI
Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database

1773例非皮肤纤维肉瘤浅表肉瘤的结局:一项来自NETSARC数据库的法国肉瘤组(FSG)研究

2025-09-120
PRE
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL)

Nardin C,Cavalieri C,Lebbé C,Gérard E,Puyraveau M,Vergara R,等人. 可切除III/IV期黑色素瘤患者的新辅助免疫检查点抑制剂治疗:一项法国全国性真实世界研究(NEOMEL). 英国皮肤病学杂志. (2025) 7:ljaf268. doi: 10.1093/bjd/ljaf268.

2025-07-140
PRE
Brain metastases from Merkel Cell Carcinoma: a nationwide retrospective study

Merkel细胞癌脑转移:一项全国性回顾性研究

2025-07-100
PRE